BARISANI DONATELLA

Ruolo: 
Professore associato
Settore scientifico disciplinare: 
BIOLOGIA APPLICATA (BIO/13)
Telefono: 
0264488304
Stanza: 
U08, Piano: P03, Stanza: 3025
Via Cadore, 48 - 20900 MONZA

Pubblicazioni

  • Mancuso, C., & Barisani, D. (2019). Food additives can act as triggering factors in celiac disease: Current knowledge based on a critical review of the literature. WORLD JOURNAL OF CLINICAL CASES, 7(8), 917-927. Dettaglio
  • Violatto, M., Casarin, E., Talamini, L., Russo, L., Baldan, S., Tondello, C., et al. (2019). Dexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine Model. ACS NANO. Dettaglio
  • Marquez, A., Kerick, M., Zhernakova, A., Gutierrez-Achury, J., Chen, W., Onengut-Gumuscu, S., et al. (2018). Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations. GENOME MEDICINE, 10(1), 97. Dettaglio
  • Romano, G., Reggi, S., Kutryb-Zajac, B., Facoetti, A., Chisci, E., Pettinato, M., et al. (2018). APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe−/−atherosclerotic mice. INTERNATIONAL JOURNAL OF CARDIOLOGY. Dettaglio
  • Giovannoni, R., Facoetti, A., Chisci, E., Reggi, S., Kutryb-Zajac, B., Bombelli, S., et al. (2018). Innovative and Efficient Oral Delivery Method of APOA-1Milano Muteins Which Retain Anti-Atherosclerotic and Anti-Inflammatory Properties. Intervento presentato a: XVIII International Symposium on Atherosclerosis, Toronto. Dettaglio